Moon K Y, Kwon C H
Department of Pharmaceutical Sciences, College of Pharmacy, St. John's University, Jamaica, New York 11439, USA.
Bioorg Med Chem Lett. 1998 Jul 7;8(13):1673-8. doi: 10.1016/s0960-894x(98)00287-x.
The presence of an alkyl substituent at N3 in the oxazaphosphorine ring stabilizes N-substituted 4-(alkylthio)cyclophosphamides from spontaneous decomposition. Based on this finding, N3-methyl-mafosfamide was synthesized and examined as a chemically stable, biooxidative prodrug of mafosfamide. This prodrug was stable in aqueous buffer (pH 7.4, 37 degrees C) and underwent N-demethylation in a time dependent manner when incubated with rat hepatic microsomes. N3-Methyl-mafosfamide was 10-fold more cytotoxic in vitro than cyclophosphamide against mouse embryo Balb/c 3T3 cells (LC50 = 3.6 microM). Preliminary in vivo antitumor evaluation against L1210 leukemia in mice showed that this prodrug was active [Increase of life span (ILS) > 29%].
在恶唑磷环的N3位存在烷基取代基可使N-取代的4-(烷硫基)环磷酰胺稳定,防止其自发分解。基于这一发现,合成了N3-甲基马磷酰胺,并将其作为马磷酰胺的化学稳定生物氧化前药进行研究。该前药在水性缓冲液(pH 7.4,37℃)中稳定,与大鼠肝微粒体孵育时会以时间依赖性方式发生N-去甲基化。N3-甲基马磷酰胺在体外对小鼠胚胎Balb/c 3T3细胞的细胞毒性比环磷酰胺高10倍(LC50 = 3.6 microM)。对小鼠L1210白血病的初步体内抗肿瘤评估表明,该前药具有活性[寿命延长(ILS)> 29%]。